I agree with DAVE160, our market is at a very low point currently as all involved are well aware, with all companies finding trading conditions very difficult. The report mentioned is very expensive to purchase and during these challenging times the authors have continued to paint a grave picture of the state of the UK companies operating in the MHE arena.

Many major MHE companies trading in the UK do not record a profit and prefer to have this returned to the parent company or via other routes.

Hopefully our industry will begin to recover in the very near future.